Skip to main content
Log in

Presence of chlorprothixene and its metabolites in breast milk

  • Short Communication
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Chlorprothixene (CPX) and CPX sulphoxide were demonstrated in breast milk from two psychotic mothers taking 200 mg CPX daily. The milk concentrations of CPX were 120 to 260% greater than in plasma. The estimated amounts of drug administered in breast milk to one of the infants were 15 and 26 µg/day for CPX and CPX sulphoxide, respectively. Accordingly, the infant dose of the parent compound would be only 0.1% of the maternal dose/kg body weight. It is not likely that CPX or its metabolite would exert any immediate pharmacological effects in the nursing infant. However, the long term effect of low doses of neuroleptic drugs in the developing infants is not yet known.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ahlenius S, Brown R, Engel I, Lundborg P (1973) Learning deficits in 4 weeks old offspring of the nursing mothers treated with the neuroleptic drug penfluridol. Arch Pharmacol (Berl) 279: 31–37

    Google Scholar 

  2. Christensen H (1974) Chlorprothixene and its metabolites in blood, liver and urine from fatal poisoning. Acta Pharmacol Toxicol 24: 16–26

    Google Scholar 

  3. Kirk L, Jørgensen A (1980) Concentrations of cix(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord, serum and milk. Psychopharmacology 72: 107–108

    Google Scholar 

  4. Lundborg P (1972) Abnormal ontogeny in young rabbits after chronic administration of haloperidol to the nursing mother. Brain Res 44: 684–687

    Google Scholar 

  5. Passwal M, Dahl SG, Refsum H (1976) Anticholinergic and cardiodepressive effects of chlorpromazine and two of its metabolites on isolated rat atria. Eur J Pharmacol 40: 249–254

    Google Scholar 

  6. Raaflaub J (1975) On the pharmacokinetics of chlorprotixene in man. Experientia 31: 557–558

    Google Scholar 

  7. Uhlir Rýznar I (1973) Appearance of chlorpromazine in the mother's milk. Activ Nerv Sup (Praha) 15: 106

    Google Scholar 

  8. Whitehead RG, Paul AA (1981) Infant growth and human milk requirements. Lancet 2: 161–163

    Google Scholar 

  9. Wiles DH, Orr MW, Kolakowska T (1978) Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 5: 172

    Google Scholar 

  10. Wilson JT, Don Brown R, Cherek PR, Daily JW, Hilman B, Jobe PC, Manno BR (1980) Drug excretion in human breast milk. Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5: 1–66

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matheson, I., Evang, A., Fredricson Overø, K. et al. Presence of chlorprothixene and its metabolites in breast milk. Eur J Clin Pharmacol 27, 611–613 (1984). https://doi.org/10.1007/BF00556901

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00556901

Key words

Navigation